Echinacea purpurea

9 studies read · 3 answers · 4 sources

Echinacea purpurea offers a faint early signal for managing cold symptoms, while evidence for preventing infections or shortening recovery remains too uncertain for dependable claims.

What it does

Strong benefits

  • Fewer infections · Helps a lot

    Respiratory and skin infections can interrupt everyday plans and comfort.

    1 trial · 1,111 people · 1 review · noticed in 2–17 weeks

Modest benefits

  • Less severe respiratory infections · Probably helps a little

    A respiratory infection can bring symptoms, medication use, or complications that disrupt daily life.

    2 trials · 216 people · noticed in 1–17 weeks

Early findings (1)
  • Faster illness recovery · Unclear if it helps

    2 trials · 166 people · noticed in 1–17 weeks

How to take it

Echinacea purpurea is a reasonable option for adults who understand that its cold-season benefits remain uncertain and, at best, small. It is not a dependable way to prevent colds or speed recovery. Avoid self-starting it if you use immune-suppressing medicines or certain antiviral medicines, and stop use urgently if signs of a serious allergic reaction appear. 12

How much

For preventing respiratory infections, studies used roughly 2,400 to 4,000 mg daily of oral Echinacea purpurea preparations over longer cold-season periods. 2 Studies that tracked returning to usual activities used about 1,800 to 4,000 mg daily, but the observed recovery benefit was trivial, so a higher dose does not create a convincing faster-recovery effect. 12 Liquid products have been studied for short periods during colds, yet symptom results remain inconsistent. 1

When

Prevention trials used echinacea daily for weeks, not as an occasional dose on the first day of a cold. 2 For short-term cold use, follow the specific product instructions because liquids and solid extracts are not interchangeable and trial schedules varied substantially. 1 Taking it with food is a practical option if it unsettles your stomach, but clinical trials do not establish a single best time of day. 1

Which form

The strongest longer-term trial coverage comes from defined oral Echinacea purpurea extracts, rather than generic tea or an unspecified “echinacea blend.” 2 Choose a label that names the species and identifies whether it uses root, aerial parts, or both. Extract composition varies enough that results from one standardized product do not automatically carry over to every capsule or tincture. 12

The dose that worked, by measure (2)
Prevent acute respiratory infections
2,800 mg2–23 weeks
Return to routine sooner
3,200 mg8–16 weeks

Who should be careful

Medicines it can clash with

  • ritonavir major
  • indinavir major
  • nevirapine major
  • efavirenz major
  • cyclosporine major
  • theophylline major
  • midazolam moderate
  • caffeine moderate

Reported side effects

  • oral aphthous ulcer severe
  • serious adverse events (unrelated fractures) severe
  • anaphylaxis severe
  • mild adverse effects mild
  • sleeplessness
  • no significant side effects reported
  • Vomiting and non-urticarial rash
  • Any adverse event (AE)

Bottles worth buying

Dosed where the research is, in a clean formula, from audited brands. Not sponsored.

How it works

Echinacea has a huge cold-season reputation. The catch is that the human research shows only a faint, small signal, not the reliable shield many labels promise. 1

Echinacea purpurea is a purple coneflower native to North America. Supplements use preparations from its roots, flowering tops, or both, sold as capsules, tablets, tinctures, and teas. Different preparations contain different amounts of its naturally occurring compounds, which makes brand-to-brand comparisons tricky. 12

Echinacea contains alkamides, compounds that interact with immune-cell signaling, including cannabinoid type 2 receptors found largely on immune cells. Think of these receptors as volume knobs on an immune alarm system: echinacea compounds appear to adjust parts of the alarm, rather than directly attacking a virus. 4 That biological activity does not translate into a dependable reduction in colds in clinical trials. 1

Studied alongside

Common questions

Does Echinacea purpurea prevent colds?

The prevention signal is small and uncertain. Some trials found fewer respiratory infections, while the overall reviewed evidence does not establish a meaningful real-world reduction in colds. 12

Should you take echinacea when a cold starts?

Short courses are common in cold-symptom trials, but results have not consistently shown easier symptoms or a faster return to normal activities. 1

Can children take echinacea?

A large trial in children found no meaningful improvement in cold duration or severity, and rash occurred more often with echinacea. Speak with a pediatric clinician before using it for a child. 3

What is the best form of echinacea?

Look for a product that clearly identifies Echinacea purpurea and the plant parts used. Trials vary widely in extracts and liquids, so one product's result does not automatically apply to another. 12

Sources

  1. 1. Echinacea for preventing and treating the common cold  (2014)
  2. 2. The effect of Echinacea purpurea on the frequency, severity and duration of upper respiratory tract infections: a randomized, double-blind, placebo-controlled study  (2012)
  3. 3. Echinacea for treating upper respiratory tract infections in children: a randomized controlled trial  (2003)
  4. 4. Echinacea alkamides are a new class of cannabinomimetics. Cannabinoid type 2 receptor-dependent and independent immunomodulatory effects  (2006)